Christopher Proctor

British American Tobacco (United Kingdom)

Papers

1

Total Citations

54

H-Index

1

About

Dr. Christopher Proctor is a leading toxicologist whose research focuses on the toxicological assessment of novel tobacco and nicotine products, particularly tobacco heating products (THPs) and electronic cigarettes. His major contributions lie in developing and applying contemporary in vitro screening approaches to evaluate the potential reduced-harm profile of these products compared to conventional cigarettes. His most-cited work, "Assessment of novel tobacco heating product THP1.0. Part 6: A comparative in vitro study using contemporary screening approaches" (2017, 54 citations), demonstrates that heating tobacco, rather than burning it, significantly reduces exposure to harmful combustion toxicants. This foundational research has been instrumental in supporting the scientific basis for harm reduction strategies in public health. Dr. Proctor’s work is widely recognized for its rigor and impact, helping to shape regulatory science and industry standards for next-generation tobacco products. His studies are frequently cited by researchers and policymakers evaluating the potential of reduced-risk alternatives to smoking.

Research Focus

Key Achievements

1
H-Index
1
Papers
54
Total Citations
54
Avg Citations/Paper
🏆 Most Cited Paper
Assessment of novel tobacco heating product THP1.0. Part 6: A comparative in vitro study using contemporary screening approaches
54 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: British American Tobacco (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago